Euclidean Capital LLC 23and Me Holding Co. Transaction History
Euclidean Capital LLC
- $906 Million
- Q3 2024
A detailed history of Euclidean Capital LLC transactions in 23and Me Holding Co. stock. As of the latest transaction made, Euclidean Capital LLC holds 10,243,122 shares of ME stock, worth $31.3 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
10,243,122
Previous 10,243,122
-0.0%
Holding current value
$31.3 Million
Previous $3.99 Million
10.24%
% of portfolio
0.4%
Previous 0.5%
Shares
2 transactions
Others Institutions Holding ME
# of Institutions
116Shares Held
82.5MCall Options Held
404KPut Options Held
292K-
New View Capital Partners I, LLC Burlingame, CA19.5MShares$59.5 Million18.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$47.6 Million0.0% of portfolio
-
Sapphire Ventures, L.L.C. Austin, TX5.29MShares$16.2 Million1.93% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$14.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.25MShares$13 Million0.0% of portfolio
About 23andMe Holding Co.
- Ticker ME
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 259,768,000
- Market Cap $795M
- Description
- 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...